Keidi S.
- Country
- Estonia
- Department
- N/A
Research Overview
Data & Insights
Has run more than one trial at 0 of 15 partner sites.
Specializations
Cardiovascular Medicine
Focused on atherosclerotic cardiovascular disease, acute coronary syndrome and atrial fibrillation management.
- Primary prevention of cardiovascular events
- Secondary prevention after myocardial infarction
- Stroke risk reduction in atrial fibrillation
- Lipid‑lowering therapies in high‑risk patients
Research integrates novel lipid modulators and antithrombotic strategies to mitigate cardiovascular morbidity.
Oncology & Hematology
Engaged in studies of non‑small cell lung cancer, colorectal cancer and hematologic malignancies such as acute myeloid leukemia.
- Targeted therapies for lung adenocarcinoma
- Immunotherapy combinations in advanced colorectal cancer
- Novel agents for acute lymphoblastic leukaemia
- Combination regimens in multiple myeloma
Efforts emphasize precision medicine approaches across solid tumours and blood cancers.
Autoimmune & Inflammatory Disorders
Specializes in rheumatoid arthritis, psoriatic arthritis and moderate to severe atopic dermatitis.
- JAK inhibitor efficacy in rheumatoid arthritis
- IL‑23 pathway blockade in psoriatic arthritis
- Biologic therapies for severe atopic dermatitis
- Long‑term safety of immunomodulators in systemic lupus erythematosus
The investigator evaluates disease‑modifying strategies that target key cytokine pathways.
Nephrology & Renal Disorders
Active in research on immunoglobulin A nephropathy, chronic kidney disease and focal segmental glomerulosclerosis.
- Proteinuria reduction with novel agents
- Renal function preservation in CKD patients
- Therapeutic approaches for FSGS
- Management of kidney disease in end‑stage renal disease
Focus includes immunologic and anti‑inflammatory interventions to slow renal progression.
Pulmonary & Respiratory Diseases
Involved in studies of idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung disease and chronic obstructive pulmonary disease.
- Antifibrotic therapy for IPF
- Combination regimens for PF‑ILD
- Bronchodilator optimization in COPD
- Management of pulmonary complications in systemic diseases
Research aims to improve lung function preservation and quality of life for patients with chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.